Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
Authors
Keywords
Alzheimer disease, Tau mouse model, Behavior, Methylene blue, Therapy
Journal
Acta Neuropathologica Communications
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-09
DOI
10.1186/s40478-015-0204-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
- (2014) María del Carmen Cárdenas-Aguayo et al. ACS Chemical Neuroscience
- Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
- (2014) Cliona Stack et al. HUMAN MOLECULAR GENETICS
- Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy
- (2014) Tara L. Spires-Jones et al. NEUROSCIENCE LETTERS
- Lost after translation: missorting of Tau protein and consequences for Alzheimer disease
- (2014) Hans Zempel et al. TRENDS IN NEUROSCIENCES
- Preparation and Characterization of Methylene blue Nanoparticles for Alzheimer’s Disease and Other Tauopathies
- (2014) Umesh Jinwal et al. Current Drug Delivery
- Mechanistic Basis of Phenothiazine-Driven Inhibition of Tau Aggregation
- (2013) Elias Akoury et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- Chaperone-mediated autophagy: roles in disease and aging
- (2013) Ana Maria Cuervo et al. CELL RESEARCH
- Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology
- (2013) Katja Hochgräfe et al. FEBS Journal
- Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
- (2013) Alex Crowe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease
- (2013) Bruno Bulic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biomarker Modeling of Alzheimer’s Disease
- (2013) Clifford R. Jack et al. NEURON
- Deciphering Alzheimer Disease
- (2013) D. Selkoe et al. Cold Spring Harbor Perspectives in Medicine
- Fluid Biomarkers in Alzheimer Disease
- (2013) K. Blennow et al. Cold Spring Harbor Perspectives in Medicine
- Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
- (2012) Ann Van der Jeugd et al. ACTA NEUROPATHOLOGICA
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
- (2012) Erin E. Congdon et al. Autophagy
- Binding of methylene blue to a surface cleft inhibits the oligomerization and fibrillization of prion protein
- (2012) Paola Cavaliere et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cysteine Reactivity Distinguishes Redox Sensing by the Heat-Inducible and Constitutive Forms of Heat Shock Protein 70
- (2012) Yoshinari Miyata et al. CHEMISTRY & BIOLOGY
- Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity
- (2012) Chronis Fatouros et al. HUMAN MOLECULAR GENETICS
- Methylene Blue Modulates Huntingtin Aggregation Intermediates and Is Protective in Huntington's Disease Models
- (2012) E. M. Sontag et al. JOURNAL OF NEUROSCIENCE
- Making the Brain Glow: In Vivo Bioluminescence Imaging to Study Neurodegeneration
- (2012) Katja Hochgräfe et al. MOLECULAR NEUROBIOLOGY
- Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors
- (2012) Lars Messing et al. NEUROBIOLOGY OF AGING
- Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models
- (2012) J.-N. Audet et al. NEUROSCIENCE
- Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
- (2012) Masato Hosokawa et al. PLoS One
- Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant
- (2011) A. Sydow et al. JOURNAL OF NEUROSCIENCE
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis
- (2011) Rosamond Lougheed et al. PLoS One
- Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity
- (2010) David X. Medina et al. BRAIN PATHOLOGY
- Autophagy and misfolded proteins in neurodegeneration
- (2010) Daniel J. Metcalf et al. EXPERIMENTAL NEUROLOGY
- Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
- (2010) John C O'Leary et al. Molecular Neurodegeneration
- Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
- (2010) Frauke van Bebber et al. NEUROBIOLOGY OF DISEASE
- Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
- (2010) Brian R. Hoover et al. NEURON
- Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy
- (2010) Tetsuaki Arai et al. NEUROPATHOLOGY
- Tau protein and tau aggregation inhibitors
- (2010) Bruno Bulic et al. NEUROPHARMACOLOGY
- Methylene blue and Alzheimer's disease
- (2009) Murat Oz et al. BIOCHEMICAL PHARMACOLOGY
- Modulation and Detection of Tau Aggregation with Small-Molecule Ligands
- (2009) Edward Chang et al. Current Alzheimer Research
- Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors
- (2009) Kurt R. Brunden et al. EXPERIMENTAL NEUROLOGY
- Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing
- (2009) Yipeng Wang et al. HUMAN MOLECULAR GENETICS
- Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability
- (2009) U. K. Jinwal et al. JOURNAL OF NEUROSCIENCE
- Cellular and molecular actions of Methylene Blue in the nervous system
- (2009) Murat Oz et al. MEDICINAL RESEARCH REVIEWS
- High absolute bioavailability of methylene blue given as an aqueous oral formulation
- (2008) Ingeborg Walter-Sack et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Potential for -Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy
- (2008) M.-M. Mocanu et al. JOURNAL OF NEUROSCIENCE
- Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine
- (2008) Serena Deiana et al. PSYCHOPHARMACOLOGY
- Clinical and pathological features of an Alzheimer's disease patient with the MAPT ΔK280 mutation
- (2007) Parastoo Momeni et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started